Pulse Biosciences, Inc. (PLSE) income statement
PLSENasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30
$45.83+0.99 (+2.21%)
Close on Nov 18, 2026Market cap $3.27BP/E –Yield –
Pulse Biosciences, Inc. income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, TTM
- Gross margin
- 0.3%
- Operating margin
- -7007.8%
- Net margin
- -6755.8%
- Return on equity, FY2025
- -74.4%
Financial strength
- Current ratio
- 9.63
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 925.7%
Valuation
- P/E ratio
- –
- Price to sales
- 2758.41
- Price to book
- 32.85
- Dividend yield
- –
See a number that looks wrong?